| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/17/1998 | US5837277 Palatable pharmaceutical compositions |
| 11/17/1998 | US5837276 Apparatus for the delivery of elongate solid drug compositions |
| 11/17/1998 | US5837270 Containing 3-chloro-3,5-dimethylphenol and zinc oxide |
| 11/17/1998 | US5837257 Use of plant extracts for treatment of HIV, HCV and HBV infections |
| 11/17/1998 | US5837254 Method of treating candida and cryptococcus fungal infections by administering gentian |
| 11/17/1998 | US5837238 Using lactobacillus reuteri for treatment of diarrhea caused by rotavirus |
| 11/17/1998 | US5837234 Cell cores and encapsulation |
| 11/17/1998 | US5837228 Drug delivery device for controlled release of drugs |
| 11/17/1998 | US5837226 Ocular microsphere delivery system |
| 11/17/1998 | US5837060 Treatment of waxy milk starch to acid hydrolysis, chromatographic separation and and accumulation |
| 11/17/1998 | US5836935 Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body |
| 11/17/1998 | US5836299 Seals for use in an aerosol delivery device |
| 11/17/1998 | CA2101356C Improvements in or relating to benzothiophenes |
| 11/16/1998 | CA2205692A1 Method of administration for a therapeutic agent utilizing suitable forms of hyaluronic acid and combinations with electroporation |
| 11/15/1998 | CA2237450A1 Preparation having increased in vivo tolerability |
| 11/14/1998 | CA2237503A1 Compositions containing difluprednate |
| 11/12/1998 | WO1998050527A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 11/12/1998 | WO1998050077A1 Solid pharmaceutical formulations containing a physical mixture of sulfoalkyl ether cyclodextrin and a therapeutic agent |
| 11/12/1998 | WO1998050055A1 Ointment for the treatment of burns and of other skin diseases |
| 11/12/1998 | WO1998050054A1 Plant extracts for the treatment of increase bone resorption |
| 11/12/1998 | WO1998050045A1 Improvements in or relating to long-acting antimicrobials |
| 11/12/1998 | WO1998050041A1 Novel prodrugs comprising fluorinated amphiphiles |
| 11/12/1998 | WO1998050040A1 Novel lipid soluble steroid prodrugs |
| 11/12/1998 | WO1998050039A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure erectile dysfunction |
| 11/12/1998 | WO1998050019A1 Stable oral pharmaceutical dosage forms |
| 11/12/1998 | WO1998050018A1 Drug delivery system |
| 11/12/1998 | WO1998050017A1 Poly(vinyl alcohol) cryogel |
| 11/12/1998 | WO1998050016A2 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
| 11/12/1998 | WO1998050015A1 Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it |
| 11/12/1998 | WO1998049910A1 Encapsulated material with controlled release |
| 11/12/1998 | WO1998027966A3 Encapsulated cells producing antibodies |
| 11/12/1998 | CA2289742A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 11/12/1998 | CA2288876A1 Drug delivery system |
| 11/11/1998 | EP0877033A1 A process for the preparation of highly monodispersed polymeric hydrophilic nanoparticles |
| 11/11/1998 | EP0877010A1 Fluorinated alkanes and their uses |
| 11/11/1998 | EP0876817A1 Remedy for keratoconjunctival diseases |
| 11/11/1998 | EP0876816A1 Capsule containing whey protein |
| 11/11/1998 | EP0876815A1 "Drug delivery system for two or more active substances" |
| 11/11/1998 | EP0876814A1 Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it |
| 11/11/1998 | EP0876611A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 11/11/1998 | EP0876159A1 Composition for treating skin affections and process for its preparation |
| 11/11/1998 | EP0876151A1 Microencapsulated genetically engineered microorganisms for clinical application |
| 11/11/1998 | EP0876145A1 Taxane composition and method |
| 11/11/1998 | EP0876142A1 Topical delivery of drugs to the lower gastrointestinal tract |
| 11/11/1998 | EP0876141A2 Preparations of non-steroidal analgesics |
| 11/11/1998 | EP0876140A2 Improved concentrated injection and infusion solutions for intravenous administration |
| 11/11/1998 | EP0876139A1 Medicament forms constituted in situ for releasing enzymes into wounds |
| 11/11/1998 | EP0876131A1 Drug delivery compositions for improved stability of steroids |
| 11/11/1998 | EP0876109A1 Water dispersible compositions containing natural hydrophobic pigment, method of preparing same and their use |
| 11/11/1998 | EP0800386B1 Transdermal system for the simultaneous delivery of a number of active principles |
| 11/11/1998 | EP0784467B1 Unitary vaginal dosage form useful as a local contraceptive and/or for combatting sexually transmitted diseases and/or hiv |
| 11/11/1998 | EP0776197B1 Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives |
| 11/11/1998 | EP0766570A4 Methods for treating respiratory disease |
| 11/11/1998 | EP0744940B1 Drugs, vaccines and hormones in polylactide coated microspheres |
| 11/11/1998 | EP0720473B1 Budesonide pellets with a controlled release pattern and process for producing them |
| 11/11/1998 | EP0693921A4 Anti-oxidant alkylaryl polyether alcohol polymers |
| 11/11/1998 | EP0632720B1 Hydroxyethylcellulose-based sustained-release oral drug dosage froms |
| 11/11/1998 | EP0586381B1 Improved blood substitute |
| 11/11/1998 | EP0577751B1 Lipid vesicle containing water-in-oil emulsions |
| 11/11/1998 | CN2296725Y Medical paster for Guanyuan acupoint for reducing abdomen weight |
| 11/11/1998 | CN1198677A Isotopic urea tablets |
| 11/11/1998 | CN1198675A Medicine comprising HGF gene |
| 11/11/1998 | CN1198673A Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 11/11/1998 | CN1198672A Gel for the local hormonotherapy of vaginal dryness |
| 11/11/1998 | CN1198666A Chewable tablet |
| 11/11/1998 | CN1198665A Unit galenical form for local hormonotherapy of vaginal dryness |
| 11/11/1998 | CN1198350A Fushuixiao oral liquor (medicine for eliminating ascites) and preparing process |
| 11/11/1998 | CN1198342A Medicine series for preventing and curing hypotension, angiocardiopathy and cerebrovascular disease and productive method thereof |
| 11/11/1998 | CN1198341A Prescription of ointment for curing onychomycosis and preparation method thereof |
| 11/11/1998 | CN1198340A Monkshood plaster |
| 11/11/1998 | CN1198332A Tongxinluo medicinal capsule for curing coronary heart disease and angina pectoris and preparation method thereof |
| 11/11/1998 | CN1198328A Medicinal (health care preparation) dry sugar granular (syrup) tablet |
| 11/11/1998 | CN1198327A Far infrared plaster |
| 11/11/1998 | CN1198323A Microstructure composition |
| 11/10/1998 | US5834556 Graft copolymer of polycationic species and water-soluble polymers, and uses therefor |
| 11/10/1998 | US5834519 Stabilized gas-supersaturated emulsions and suspensions |
| 11/10/1998 | US5834510 Topical application |
| 11/10/1998 | US5834451 Remedy for myotonic dystrophy |
| 11/10/1998 | US5834448 Dosage form of hydroxocobalamin and its use in cyanide poisoning |
| 11/10/1998 | US5834444 Hyaluronic acid and salts thereof inhibit arterial restenosis |
| 11/10/1998 | US5834441 Introducing a genetic sequence into a host cell |
| 11/10/1998 | US5834439 Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
| 11/10/1998 | US5834274 Free radical photopolymerizable |
| 11/10/1998 | US5834232 Cross-linked gelatin gels and methods of making them |
| 11/10/1998 | US5834032 Compositions and methods for treating diabetes |
| 11/10/1998 | US5834028 Storage stable solutions with maltose, lactose or sucrose and arginine hydrochloride; for treatment or prevention of blood coagulation disorders |
| 11/10/1998 | US5834025 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
| 11/10/1998 | US5834024 Controlled absorption diltiazem pharmaceutical formulation |
| 11/10/1998 | US5834023 Diltiazem controlled release formulation |
| 11/10/1998 | US5834022 Water soluble pharmaceutical coating and method for producing coated pharmaceuticals |
| 11/10/1998 | US5834021 Rate of dissolution at ph 6.5 is increased by the presence of a rheological modifying super-disintegrant, especially croscarmellose; insufficient to cause disintegration of the prednisolone compound itself; solid enteric |
| 11/10/1998 | US5834019 Pharmaceutical formulation containing a hydrophobic active substance and an effervescent system |
| 11/10/1998 | US5834017 Oral cyclopsporin formulations |
| 11/10/1998 | US5834016 Mixtures of (di-)hydroxycholecalciferol, lecithins, cholesterol or its organic acid or (poly)ethylene glycol derivatives and a lower alkyl alcohol; for treatment of psoriasis, good skin penetration |
| 11/10/1998 | US5834015 Protein-lipid vesicles and autogenous vaccine comprising the same |
| 11/10/1998 | US5834014 Modifying minoxidil with alpha-hydroxy acid to make it more hydrophilic, encapsulating in a lipid vesicle of glycerol dilaurate; improved penetration for topical delivery |
| 11/10/1998 | US5834013 Topical skin hydrating composition |
| 11/10/1998 | US5834012 Lipid complexed topoisomerase I inhibitors |
| 11/10/1998 | US5834010 Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
| 11/10/1998 | US5834008 Composition and method for acceleration of wound and burn healing |